| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/22/2009 | WO2009062950A1 Novel compounds |
| 05/22/2009 | WO2009062258A1 N-containing heterocyclic compounds |
| 05/22/2009 | CA2705916A1 Benzazepinone compound |
| 05/22/2009 | CA2705586A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
| 05/22/2009 | CA2703600A1 N-containing heterocyclic compounds |
| 05/21/2009 | US20090131668 4-oxo-4,6,7,8-Tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 05/21/2009 | US20090131663 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES |
| 05/21/2009 | US20090131662 Compositions And Methods Pertaining To PNA Synthons And Oligomers Comprising A Universal Base |
| 05/21/2009 | US20090131624 Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| 05/21/2009 | US20090131502 Biologically active compounds |
| 05/21/2009 | US20090131501 Alzheimer's disease; administering orally (+) phenserine; phenserine tartrate; racemic or enantiomerically pure; not toxic in a wide range of dosages |
| 05/21/2009 | US20090131500 Porphyrin derivates and their use as photosensitizers in photodynamic therapy |
| 05/21/2009 | US20090131457 Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders |
| 05/21/2009 | US20090131446 Fused pyrazine compounds useful for the treatment of degenerative and inflmmatory diseases |
| 05/21/2009 | US20090131435 Heterocyclic inhibitors of mek and methods of use |
| 05/21/2009 | US20090131425 Inhibitors of protein kinases |
| 05/21/2009 | US20090131409 1,4,5,6,7,8-HEXAHYDRO -PYRROLO[2,3-d]AZEPINES AND -IMIDAZO[4,5-d]AZEPINES AS MODULATORS OF NUCLEAR RECEPTOR ACTIVITY |
| 05/21/2009 | US20090131407 Tetracyclic kinase inhibitors |
| 05/21/2009 | US20090131397 Estrogen modulators |
| 05/21/2009 | US20090131393 Process for Preparing Chlorides of Phthalocyanine Derivatives Comprising at Least a Quaternary Ammonium Group |
| 05/21/2009 | US20090130057 Compounds for the Treatment of Hepatitis C |
| 05/21/2009 | US20090130049 Self-Sterilizing Products |
| 05/21/2009 | US20090128013 arylaton and acylation of 2,5-dimethyl-1,4-phenylenediamine; emits blue light with high color purity, high electrical stability; for high efficiency, low driving voltage, high brightness, and long lifetime devices |
| 05/20/2009 | EP2060574A1 Heterocyclic compound and an organic light emitting device comprising the same |
| 05/20/2009 | EP2059521A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 05/20/2009 | EP2059520A1 1,4,5,6, 7,8-hexahydro-i^1s-triaza-azulene derivatives as orexin receptor antagonists |
| 05/20/2009 | EP1773348A4 Tetrapeptide analogs |
| 05/20/2009 | EP1607091B1 Antihepatitis c virus agent and anti-hiv agent |
| 05/20/2009 | EP1392691B1 Antifungal 4-substituted 5,6-dihydro-4h-pyrrolo[1,2-a] [1,4] benzodiazepines |
| 05/20/2009 | CN101437826A Pentacyclic indole derivatives as antiviral agents |
| 05/20/2009 | CN101437825A Fused heterocylic compounds and their use as mGluR5 modulators |
| 05/20/2009 | CN101437824A Inhibitors of secretion of hepatitis B virus antigens for treatment of a chronic hepatitis virus |
| 05/20/2009 | CN101437816A 2-aminopyridine analogs as glucokinase activators |
| 05/20/2009 | CN101437512A Glucokinase activators |
| 05/20/2009 | CN101434605A Heterocyclic compound and an organic light emitting device comprising the same |
| 05/20/2009 | CN101434604A Condensed n-heterocyclic compounds and their use as CRF receptor antagonists |
| 05/20/2009 | CN101434596A Novel azaheterocyclic amides useful for treating pain |
| 05/20/2009 | CN101433565A Total alkaloid extract of seeds of harmel genus and effective monomer component thereof, and preparation and use thereof |
| 05/20/2009 | CN100488966C Branchy porphyrin molecule with intramolecular energy transfer and two-photon absorption characteristics |
| 05/20/2009 | CN100488965C Water soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
| 05/20/2009 | CN100488952C 5-phenyl pyridine, its preparation method and intermediate product and uses in controlling harmful fungus |
| 05/20/2009 | CN100488923C Double-loop coil organic compounds and electric-field luminescent devices |
| 05/19/2009 | US7534882 Method for preparing pyrrolotriazine compounds via in situ amination of pyrroles |
| 05/19/2009 | US7534881 Method for preparing pyrrolotriazine compounds |
| 05/19/2009 | US7534797 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 05/19/2009 | US7534795 Compounds and their use related to compositions for treating disease |
| 05/19/2009 | US7534792 Pyrrolotriazine kinase inhibitors |
| 05/19/2009 | US7534767 4-amino-7-(2-C-methyl- beta -D-ribofuranosyl)-furo[3,2-d]pyrimidine; 7-amino-3-(2-C-methyl- beta -D-ribofuranosyl)-1H-pyrazolo[4,3-d]pyrimidine; -amino-7-(2-C-methyl- beta -D-ribofuranosyl)-5H-pyrrolo[3,2-d]pyrimidine; hepatitis C virus (HCV) infection |
| 05/19/2009 | CA2498047C Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 05/19/2009 | CA2407929C Treatment of congestive heart failure with a composition comprising a diuretic agent and a vasopressin antagonist |
| 05/19/2009 | CA2336634C Antiviral macrocyclic compounds |
| 05/14/2009 | WO2009062118A2 Modulation of protein trafficking |
| 05/14/2009 | WO2009061699A1 Gamma secretase modulators |
| 05/14/2009 | WO2009061676A2 Antagonists of pgd2 receptors |
| 05/14/2009 | WO2009060292A2 Smac mimetic compounds as apoptosis inducers |
| 05/14/2009 | WO2009060206A1 3,4,6,7-tetrahydro-1h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use |
| 05/14/2009 | WO2009060203A1 3,4,6,7-tetrahydro-1 h-pyrrolo[3,4-d]pyrimidine-2,5-diones and their therapeutic use |
| 05/14/2009 | WO2009060197A1 Imidazopyridazines for use as protein kinase inhibitors |
| 05/14/2009 | WO2009060158A1 4- (4-cyanophenyl) -1- (3-trifluoromethylphenyl) -3,4, 6, 7-tetrahydro-1h-pyrrolo [3, 4- d] pyrimidine-2, 5-dione derivatives and their use as human neutrophil elastase inhibitors |
| 05/14/2009 | WO2009037357A4 Benzimidazole nf- kappab inhibitors |
| 05/14/2009 | WO2008144507A3 Spirooxindole inhibitors of aurora kinase |
| 05/14/2009 | US20090124802 Diaryl-purines, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitor for treatment of hiv |
| 05/14/2009 | US20090124668 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/14/2009 | US20090124640 Pyrrolo[3,2-D]Pyrimidin-4-One Derivative as Myeloperoxidase Inhibitor |
| 05/14/2009 | US20090124638 Anti-inflammatory pyrazolopyrimidines |
| 05/14/2009 | US20090124621 Pyrazole derivatives as kinase inhibitors |
| 05/14/2009 | US20090124612 Fused heterocyclic derivatives and methods of use |
| 05/14/2009 | US20090124609 Fused heterocyclic derivatives and methods of use |
| 05/14/2009 | US20090124607 Novel Bicyclic Sulfonamides for Use as Glucocorticoid Receptor Modulators in the Treatment of Inflammatory Diseases |
| 05/14/2009 | US20090124605 Pyrazolo-Quinazoline Derivatives, Process for Their Preparation and Their Use as Kinase Inhibitors |
| 05/14/2009 | US20090124600 N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists |
| 05/14/2009 | US20090121617 Electronic devices made with electron transport and/or anti-quenching layers |
| 05/14/2009 | CA2705303A1 Modulation of protein trafficking |
| 05/14/2009 | CA2704698A1 Gamma secretase modulators |
| 05/13/2009 | EP2058314A1 Pyrrolotriazine compounds as kinase inhibitors |
| 05/13/2009 | EP2058313A2 Process for synthesis and purification of anhydrous crystalline S-zopiclone |
| 05/13/2009 | EP2058312A1 SMAC mimetic compounds as apoptosis inducers |
| 05/13/2009 | EP2057167A2 Porphyrin derivates and their use as photosensitizers in photodynamic therapy |
| 05/13/2009 | EP2057166A2 Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro- pyrazoloý1,5-a¨pyrimidin-7-yl)-amino derivatives and intermediates |
| 05/13/2009 | EP2057165A1 Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
| 05/13/2009 | EP2057164A1 Triazolotriazines as kinase inhibitors |
| 05/13/2009 | EP2057163A1 Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase |
| 05/13/2009 | EP2057162A2 Fused heterocyclic inhibitors of d-amino acid oxidase |
| 05/13/2009 | EP2057161A2 4-oxo-4,5-dihydropyrrolo[1,2-a]quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 05/13/2009 | EP2057160A1 Pyrrolo [3, 2 -d]pyrimidines as dpp-iv inhibitors for the treatment of diabetes mellitus |
| 05/13/2009 | EP2057141A1 Pyrimidone compounds as gsk-3 inhibitors |
| 05/13/2009 | EP2057125A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/13/2009 | EP1305026B1 Barbituric acid analogs as therapeutic agents |
| 05/13/2009 | EP1299388B1 Variolin derivatives as anti-cancer agents |
| 05/13/2009 | CN101432287A Pyrrolopyrimidine derivatives used as HSP90 inhibitors |
| 05/13/2009 | CN101432284A Dihydropyrazolopyrimidinone derivative |
| 05/13/2009 | CN101432265A Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/13/2009 | CN101432000A Prophylactic or therapeutic agent for allergic ophthalmic disease or allergic nasal disease comprising tricyclic triazolobenzoazepine derivative |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/13/2009 | CN100486580C 6-aryl-7-halo-imidazo[1,2-A]pyrimidines as anticancer agents |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/12/2009 | US7531553 Heterocyclic compounds and methods of use |
| 05/12/2009 | US7531546 inhibitors of cysteine proteases; neuropathic pain, inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, tumors, obesity, coronary disease, atherosclerosis; 6-(2-Acetyl-2,8-diaza-spiro[4.5]dec-8-ylmethyl)-7-(2-cyclohexyl-ethyl)-7H-pyrrolo[2,3d]pyrimidine-2-carbonitrile |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531539 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines |